Emergent's Vaccine Portfolio Aids Growth Amid Competition - Yahoo Finance

Emergent's Vaccine Portfolio Aids Growth Amid Competition  Yahoo Finance

Emergent's (EBS) vaccine portfolio holds potential with the newly-acquired Narcan nasal spray performing well in the first half of 2019. Stiff competition is a ...